This topic contains a solution. Click here to go to the answer

Author Question: A patient has been taking a drug that has a protein-binding effect of 75. The provider adds a new ... (Read 71 times)

Alygatorr01285

  • Hero Member
  • *****
  • Posts: 564
A patient has been taking a drug that has a protein-binding effect of 75. The provider adds a new medication that has a protein-binding effect of 90. The nurse will expect
 
  a. decreased drug effects of the first drug.
  b. decreased therapeutic range of the first drug.
  c. increased drug effects of the first drug.
  d. increased therapeutic range of the first drug.

Question 2

The nurse is administering two drugs to a patient and learns that both drugs are highly protein-bound. The nurse may expect
 
  a. decreased bioavailability of both drugs.
  b. decreased drug effects.
  c. decreased drug interactions.
  d. increased risk of adverse effects.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

vickybb89

  • Sr. Member
  • ****
  • Posts: 347
Answer to Question 1

ANS: C
Adding another highly protein-bound drug will displace the first drug from protein-binding sites and release more free drug increasing the drug's effects. This does not alter the therapeutic range, which is the serum level between drug effectiveness and toxicity.

Answer to Question 2

ANS: D
Two drugs that are highly protein-bound will compete for protein-binding sites, leaving more free drug in circulation and an increased risk of adverse effects as well as increased bioavailability, increased drug effects, and increased drug interactions.




Alygatorr01285

  • Member
  • Posts: 564
Reply 2 on: Jul 23, 2018
Wow, this really help


steff9894

  • Member
  • Posts: 337
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

Cucumber slices relieve headaches by tightening blood vessels, reducing blood flow to the area, and relieving pressure.

Did you know?

When blood is deoxygenated and flowing back to the heart through the veins, it is dark reddish-blue in color. Blood in the arteries that is oxygenated and flowing out to the body is bright red. Whereas arterial blood comes out in spurts, venous blood flows.

Did you know?

Drugs are in development that may cure asthma and hay fever once and for all. They target leukotrienes, which are known to cause tightening of the air passages in the lungs and increase mucus productions in nasal passages.

For a complete list of videos, visit our video library